✦ LIBER ✦

Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state

✍ Scribed by Anders Dahm; Frits R. Rosendaal; Trine O. Andersen; Per M. Sandset

Book ID: 108673552
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 87 KB
Volume: 132
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2005.05876.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interaction between tissue factor pathwa

Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis

✍ A. E. A. DAHM; I. D. BEZEMER; P. M. SANDSET; F. R. ROSENDAAL 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Systemic lupus erythematosus in a multie

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients

✍ Jaime Calvo-Alén; Sergio M. A. Toloza; Mónica Fernández; Holly M. Bastian; Barri 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

## Abstract ## Objective Venous thrombosis is a relatively frequent and serious complication in systemic lupus erythematosus (SLE) that has been associated with the presence of antiphospholipid antibodies (aPL). However, venous thrombotic events can also be seen in patients without aPL, and only a